Xue J, Astère M, Zhong M, Lin H, Shen J, Zhu Y. Onco Targets Ther. 2018;11:6119–6128.
The article type for this paper was listed as a “Review” and it needs to be changed to “Original Research”.
. 2019 Apr 11;12:2749. doi: 10.2147/OTT.S210748
Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis [Corrigendum]
Received 2019 Apr 1; Accepted 2019 Apr 1; Collection date 2019.
© 2019 Xue et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
PMCID: PMC6489555 PMID: 31114226
This corrects the article "Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis" in volume 11 on page 6119.